المؤلفون: YASUHISA HASHINO, TAKUMU MATUSHITA, TAE HATSUYAMA, AZUSA WAKAMOTO, KEISUKE GOTO, TAKANOBU HOSHI, KUNINORI IWAYAMA, KOICHI OHTAKI, TAKAKI TODA, HIDEKI SATO

المصدر: In Vivo; Mar/Apr2024, Vol. 38 Issue 2, p864-872, 9p

مصطلحات موضوعية: DRUG side effects, LUNG cancer treatment, PEMBROLIZUMAB, NON-small-cell lung carcinoma, CANCER prognosis